Information updates

Allergen Immunotherapy Symposium 17th March 2022

Stallergenes Greer is hosting a 'Perspectives in AIT: 2022 and Beyond' scientific symposium as a webinar on Thursday 17th March 2022 6.00 – 7.30 pm AEDST (5.00 - 6.30 pm Brisbane / 5.30 – 7.00 pm Adelaide / 3.00 – 4.30 pm Perth / 8.00 – 9.30 pm Auckland).  The program and presenters are listed below.

To register go to https://us02web.zoom.us/meeting/register/tZUkd-6spjwrHNyyWuMIJxbrUnx-O1sXbOFr

For more details please refer to the pdf: pdfAllergen Immunotherapy 17 March 2022 Invitation162.73 KB

PLENARY (30 min): Evidence-based approaches to house dust mite ait: international insights and trends.

Prof. Oliver Pfaar (Germany)
Head of the Section Rhinology and Allergy, ORL-Department at University Hospital Marburg, Germany

EXPERT PANEL (30 min): Burdens, risks and optimal management of springtime allergy: latest australian data

Featuring ‘snapshots’ of the very latest local research presented by:

Prof. Jo Douglass (Melbourne)
James Stewart Chair of Medicine, University of Melbourne; Director of Research, Royal Melbourne Hospital

Prof. Sheryl van Nunen OAM (Sydney)
Clinical Professor, Macquarie University; Clinical Associate Professor, Northern Clinical School, University of Sydney; Visiting Medical Officer, Northern Beaches Hospital

Prof. Simon Haberle (Canberra)
Professor of Natural History, Director of the School of Culture, History and Language, Australian National University; Pollen lead for AirRater, ACT

A/Prof. Ed Newbigin (Melbourne)
Botanist, School of BioSciences, University of Melbourne; Co-ordinator, Melbourne Pollen Count Team

COMBINED Q&A SESSION (30 min): Prof. Pfaar and the Australian Expert Panel will provide a platform to explore an overarching question: Based on the latest science, what approaches and future directions would inform the prescription of AIT to allergy sufferers in Australia?

Chair: A/Prof. Kymble Spriggs
Clinical Associate Professor, University of Melbourne

 

This news item was issued on 24 February 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.  

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.